KARA FITZGERALD, ND completed a post-doctorate in nutritional biochemistry/laboratory science with Richard Lord, Ph.D. Author: Case Studies in Integrative and Functional Medicine, contributing author: Laboratory Evaluations for Integrative and Functional Medicine; IFM’s Textbook for Functional Medicine. She lectures globally on functional medicine; is on faculty at IFM and practices in Connecticut.

Podcast album cover

Episode 86: Sponsored | Panoramic Microbial Assessment: The GI360™ Stool Test with David Quig, PhD

The GI360 is a smart, evidenced-based stool test that is easily actionable by the clinician. Listen to my conversation today with VP of Scientific Support from Doctor’s Data, Dr. David Quig. One of the most useful tools I am aware of in stool testing is the Dysbiosis Test, which identifies and characterizes more than 45 targeted analytes across six Phyla using PCR and compares the patient results to a characterized normobiotic reference population. DDI is also using the Luminex PCR panel for pathogens, parasites and viruses – an FDA cleared panel for accurate detection of microbes that are almost always a problem. But what if they are not? Hear my discussion with Dr. Q on that. Finally, beta glucuronidase – it’s SO MUCH more complex than we’ve understood. Yes, we’re aware of the estrogen connection, but the BG story has evolved. We also walk through the chemistries – DDI includes a wide range of chems (appreciated by me and my colleagues here in our practice!). Give a listen, and leave us a review wherever you listen to New Frontiers! Thank you! ~DrKF

No Further Trials Needed to Determine if Omega-3 Fats Reduce the Risk of Cardiovascular Disease and Death

This new meta-analysis indicates that ‘no further trials are needed to better evaluate the efficacy of PUFAs in preventing death related to CVD”. A total of 100,609 patients were analyzed. Reduction in mortality due to cardiovascular issues was statistically significant with a relative risk of 0.937, CI 0.88-0.98, P=0.018. Is it time to put this decades-long debate to bed? We think so.

Higher Serum Chemicals Linked with Celiac Disease

Having increased exposure to environmental chemicals, such as those found in pesticides, non-stick cookware, and fire retardants, is positively associated with increased incidence of Celiac Disease. Specifically, young individuals with high serum levels of dichlorodiphenyldichloroethylene (DDE) are twice as likely to have developed Celiac Disease. When looking at females only, the risk is even greater…

Diet is a Significant Underlying Driver of Acne

A new study of 24,452 participants published in JAMA Dermatology confirms what we see in clinic – that diet makes a huge difference in acne. In particular, foods that are high in a combination of fat and sugar, sugary drinks, and dairy products are associated with adult acne. Our success in treating acne comes from the review of all potential drivers of immune reactivity and inflammation that can be unique to each individual.

New Preprint Article – DrKF’s Latest Analysis on Furin’s Connection to SARS Cov-2 and Treatment Implications Now Available on SSRN

My research and analysis on the important connections between furin and SARS CoV-2 has been accepted as a preprint article on SSRN. Thank you, David Riley, for making that happen! Abstract: Furin is a protease that is ubiquitous in the mammalian metabolism. One of the innovations that make SARS-CoV-2 more infectious than its ancestor viruses…

The Furin-COVID-19 Connection Continues but Key Aspects are Missing From the Discussion

More validation is emerging for the furin protease (“furin”) hypothesis I posited in this blog: The Furin Protease Connection: From SARS CoV-2 and Anthrax, to Diabetes and Hypertension and that is now available as a pre-print publication here. Considering furin protease inhibitors Scientists are validating furin inhibition as a possible pathway to addressing COVID. And in this Medical News Today…

Blood Pressure Medications Don’t Increase Risk for Severe COVID-According to New Wuhan Data Analysis

Potential good news for those with high blood pressure… taking antihypertensive medication, including ACE-inhibitors and ARBs, does not seem to increase the risk of more severe COVID-19 infection. This is based on a collective meta-analysis of group data from Wuhan, China reported in the European Heart Journal. This had previously been a potential concern since…